Goal: Prevent illness and disability related to blood disorders.

Millions of people in the United States carry genes that can cause blood disorders like sickle cell disease and hemophilia. Healthy People 2030 focuses on improving health and quality of life for people who have blood disorders.

Sickle cell disease is a blood disorder that affects more than 100,000 people in the United States.1 Interventions, like strategies to increase use of hydroxyurea, can improve the health outcomes of people with sickle cell disease, and blood transfusions can help prevent and treat complications.

Hemophilia is a chronic bleeding disease that mainly affects males. Interventions to promote preventive treatments can reduce joint damage and disability in people with hemophilia.2

Objective Status

  • 2 Baseline only
  • 2 Developmental
  • 0 Research

Learn more about objective types

References

1.

Centers for Disease Control and Prevention. (2019). Data & Statistics on Sickle Cell Disease. Retrieved from https://www.cdc.gov/ncbddd/sicklecell/data.html

2.

Centers for Disease Control and Prevention. (2019). Data & Statistics on Hemophilia. Retrieved from https://www.cdc.gov/ncbddd/hemophilia/data.html